Signafuse is indicated for the posterolateral spine, extremities and pelvis as well as a bone graft extender in the posterolateral spine. It is comprised of a biphasic mineral and bioactive glass suspended in a resorbable polymer carrier.
BioStructures is a privately held orthobiologics company.
More Articles on Devices:
Medtronic 3Q Spine Revenues Up, BMP Continues Slump
OrthAlign Signs Exclusive Distribution Agreement With Biomet Japan for KneeAlign
Is Biomet Next to Form IPO?
